| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1097.1B | ¥1296.6B | -15.4% |
| Operating Income | ¥32.2B | ¥67.1B | -52.0% |
| Ordinary Income | ¥29.6B | ¥66.1B | -55.2% |
| Net Income | ¥16.7B | ¥45.3B | -63.2% |
| ROE | 1.6% | 4.2% | - |
FY2025 Q3 results show revenue of 109.7B yen (YoY -15.4%), operating income of 3.2B yen (YoY -52.0%), ordinary income of 3.0B yen (YoY -55.2%), and net income of 1.7B yen (YoY -63.2%). The quarter demonstrates significant deterioration in profitability with operating margin contracting to 2.9% from 5.2% in the prior year period. Gross profit margin declined to 12.2% while selling, general and administrative expenses remained largely flat at 10.2B yen, resulting in negative operating leverage. Non-operating expenses exceeded non-operating income by 0.3B yen, including interest expenses of 0.1B yen. Extraordinary losses of 0.5B yen from disposal of fixed assets further compressed net income. Despite weak earnings, cash and deposits increased 55.1% YoY to 23.8B yen, supported by working capital reduction through inventory decrease of 30.2% and accounts receivable decline. The balance sheet remains solid with equity ratio of 71.5%, current ratio of 333.4%, and low interest-bearing debt of 8.7B yen.
[Profitability] ROE of 1.6% represents significant underperformance compared to prior year levels, driven by net profit margin compression to 1.5% from approximately 3.5% in the prior year period. Operating margin of 2.9% (down 2.3pt YoY from 5.2%) and EBIT margin of 2.9% indicate severe pressure on core business profitability. Gross profit margin of 12.2% combined with SGA expenses of 10.2B yen resulted in minimal operating profit generation. The DuPont analysis reveals ROE composition of net profit margin 1.5%, asset turnover 0.731 times, and financial leverage 1.40 times. Tax burden coefficient of 0.662 and interest burden coefficient of 0.783 (indicating 22% of pre-interest profit consumed by interest expenses) further reduced return metrics. ROIC of 2.3% falls substantially below capital cost expectations. [Cash Quality] Cash and cash equivalents of 23.8B yen provide coverage of 9.42 times over short-term debt of 2.5B yen. However, working capital efficiency shows significant concerns with accounts receivable turnover of 92 days (DSO), inventory turnover of 107 days (DIO), and cash conversion cycle of 141 days, all substantially exceeding manufacturing industry norms. [Investment Efficiency] Total asset turnover of 0.731 times and working capital turnover metrics indicate room for improvement in asset utilization efficiency. [Financial Health] Equity ratio of 71.5% (equity 107.3B yen against total assets 149.9B yen) demonstrates strong capitalization. Current ratio of 333.4% and quick ratio of 289.6% reflect robust liquidity position. Debt-to-equity ratio of 0.40 times and total interest-bearing debt of 8.7B yen indicate conservative leverage. Interest coverage ratio of 22.65 times provides comfortable debt servicing capacity.
Cash and deposits increased 8.4B yen YoY (up 55.1%) to reach 23.8B yen, representing a substantial liquidity enhancement despite weak operating performance. The primary drivers of cash accumulation were working capital optimization through inventory reduction of 5.2B yen (down 30.2% to 12.0B yen) and accounts receivable decrease of 5.6B yen (from 33.4B yen to 27.8B yen), converting operating assets into cash. Trade payables decreased 2.2B yen, partially offsetting the working capital benefit. The significant cash buildup during a period of profit decline suggests aggressive working capital management and potential asset monetization rather than strong operating cash generation from earnings. While the cash coverage of short-term liabilities at 9.42 times indicates excellent near-term liquidity security, the sustainability of this cash position depends on operating profit recovery. The balance between cash accumulation and declining profitability warrants monitoring, particularly given the elevated dividend payout that may pressure future cash reserves if earnings do not improve.
Ordinary income of 3.0B yen versus operating income of 3.2B yen shows net non-operating expense of approximately 0.3B yen. Non-operating expenses of 0.6B yen exceeded non-operating income of 0.3B yen, with interest expenses of 0.1B yen representing the primary financial cost. The non-operating impact relative to revenue is modest at approximately 0.5% of sales. Extraordinary losses totaling 0.5B yen from fixed asset disposals represent 31.3% of net income, indicating significant one-time charges affecting bottom-line results. The tax burden with an effective rate of 33.7% resulted in net income of 1.7B yen from pre-tax profit of 2.5B yen. Earnings quality shows mixed signals: while the one-time nature of extraordinary losses suggests core earnings potential above reported net income, the severely compressed EBIT margin of 2.9% and low net profit margin of 1.5% indicate fundamental operational challenges beyond temporary factors. The absence of operating cash flow disclosure limits full assessment of cash-backed earnings quality, though the working capital improvements and cash accumulation provide partial validation of earnings substance.
Revenue contraction of 15.4% YoY coupled with gross margin compression to 12.2% indicates exposure to pricing pressure, unfavorable product mix, or raw material cost inflation that severely impacts profitability. Full-year guidance projects revenue of 148.0B yen (down 12.6% YoY) with operating income of 4.2B yen, requiring significant Q4 improvement from Q3 run rates to achieve targets. Working capital efficiency deterioration with DSO of 92 days, DIO of 107 days, and CCC of 141 days substantially exceeds manufacturing sector norms and ties up capital that could otherwise support operations or investment. Quarterly dividend per share totaling 40.0 yen against net income per share results in a calculated payout ratio of 151.3%, raising sustainability concerns as dividend payments exceed current earnings, though the 23.8B yen cash position provides near-term coverage capacity.
[Industry Position] (Reference - Proprietary Analysis) Profitability: Operating margin 2.9% versus industry median 8.3% positions the company in the lower quartile of manufacturing sector profitability. Net profit margin of 1.5% compares unfavorably to industry median of 6.3%, indicating significant underperformance in converting revenue to profit. ROE of 1.6% falls well below the industry median of 5.0%, reflecting weak return generation on shareholder equity. ROIC of 2.3% versus industry median of 5.0% demonstrates subpar capital efficiency. Financial Health: Equity ratio of 71.5% exceeds industry median of 63.8%, indicating stronger capitalization and conservative financial leverage. Current ratio of 333.4% substantially surpasses industry median of 2.84 times, demonstrating superior liquidity positioning. Efficiency: Asset turnover of 0.731 times exceeds industry median of 0.58 times, suggesting relatively effective asset utilization despite profitability challenges. However, receivables turnover of 92 days exceeds industry median of 83 days, inventory turnover of 107 days approximates industry median of 109 days, and cash conversion cycle of 141 days is elevated compared to industry median of 108 days, indicating working capital efficiency below industry standards. Growth: Revenue contraction of 15.4% YoY significantly lags industry median growth of 2.7%, placing the company among the weakest performers in sales momentum. ※ Industry: Manufacturing (98 companies for most metrics), Comparison: FY2025 Q3, Source: Proprietary analysis
Structural profitability challenges require urgent attention as operating margin of 2.9% and net margin of 1.5% rank significantly below manufacturing industry medians of 8.3% and 6.3% respectively, indicating fundamental business model or competitive positioning issues beyond cyclical factors. The combination of 15.4% revenue decline with fixed cost base (SGA expenses remaining flat at 10.2B yen) demonstrates negative operating leverage, while the company's full-year guidance implies required substantial Q4 recovery that appears challenging given Q3 momentum. Working capital management presents both a risk and opportunity, as the 141-day cash conversion cycle substantially exceeds the 108-day industry median, yet Q3's successful inventory reduction (down 30.2%) and receivables collection generated significant cash flow of 8.4B yen, demonstrating management's capability to improve efficiency when focused on working capital optimization. Financial position provides a cushion for operational restructuring with equity ratio of 71.5% exceeding industry median of 63.8%, cash holdings of 23.8B yen covering short-term debt 9.42 times, and conservative debt-to-equity of 0.40 times, though the dividend payout ratio of 151.3% against current earnings raises capital allocation sustainability questions absent near-term profit recovery.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.